MedTrace Logo

American Breast Laser Ablation Therapy Evaluation

NCT00807924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2023-08-04

No results posted yet for this study

Summary

The purpose of this patient tracking program is to monitor long term safety and effectiveness of the Novilase™ device and method in real world application.

Conditions

  • Benign Breast Conditions; Breast Fibroadenomas

Sponsors & Collaborators

  • Novian Health Inc.

    lead INDUSTRY

Principal Investigators

  • Margaret Chen, MD · Optum ProHealthcare

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2017-08-28
Completion
2018-08-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00807924 on ClinicalTrials.gov